{"id":205400,"name":"GRAIL LLC","slug":"grail-llc","state":"CA","country":"United States of America","description":"Biotechnology company","totalSpending":1270000,"filings":24,"yearlySpending":[{"year":2020,"income":150000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"LBR","display":"Labor Issues/Antitrust/Workplace"}],"firms":["MILLER STRATEGIES, LLC"],"lobbyists":["JEFFREY MILLER","ASHLEY GUNN","JONATHAN HILER","STEPHEN RUPPEL","JESSICA MANDEL"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)"],"sampleDescriptions":["Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening. Medicare issues as they relate to oncology and early multi-cancer detection, includi","Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening. Medicare issues as they relate to oncology and early multi-cancer detection, includi","Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.","Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.","Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening."]}